HealthCRED Secures USD 1.2 Million in Seed Funding to Revolutionise B2B Healthcare Financing in India

▴ HealthCRED
HealthCRED is India’s first B2B healthcare financing startup. The fresh funds will be used to enhance customer relationships, expand operations and develop state-of-the-art service

12th August 2024, New Delhi: HealthCRED, India’s first B2B healthcare financing startup, announced today that it has raised USD 1.2 million in a seed funding round. The round was led by Antler India, TRTL VC, DeVC, iSeedVC and Angel List India. The round also saw participation from prominent angel investors including Dr. Subho Ray (President, IAMAI), Nitin Gupta (CEO, Uni Cards), Amit Lakhotia (CEO, ParkPlus) and founders of InsuranceDekho and SEA-based Docquity. The infusion of capital will be strategically utilized to enhance customer relationships and expand operations to the Southern and Western parts of the country. It will also be channelised to hire fresh talents and develop state-of-the-art B2B loan onboarding and loan management systems, creating an end-to-end digitised B2B healthcare lending framework. 

Founded in 2022 by Shrey Jain and Arpit Jangir, HealthCRED is poised to become India’s first healthcare-focused Small Finance Bank (SFB). The company provides swift, comprehensive, and adaptable financing solutions tailored for the healthcare sector. HealthCRED’s collaborative approach involves partnering with Hospitals, specialised Healthcare Service Providers (HSPs across nephrology, oncology, and diagnostics), Insurers, and Pharmaceutical and Consumable Supply Chain partners to deliver intelligent and efficient financing solutions.

Shrey Jain, Co-Founder & CEO of HealthCRED commented, "With the rapid penetration of health insurance in the post-COVID scenario, there has been an increased working capital management stress for Hospitals and HSPs. The key factor is the delay associated with the realisation of insurance receivables. Our aim is to work towards stabilising their cash flow cycles, through early financing of these delayed receivables. This would help further ensure quality delivery of patient care, thereby enabling improved alignment with SDG Target 3.8 and Universal Healthcare Coverage (UHC)".

Nitin Sharma, Partner at Antler India said, The healthcare ecosystem faces a significant working capital gap, particularly impacting small to mid-sized hospitals with limited capital access and claims management capabilities. This gap is expected to widen with increasing health insurance penetration and delayed insurer payments. Banks and NBFCs typically focus on large hospital infrastructural loans, leaving small hospitals underserved. HealthCRED aims to address this by offering working capital finance against cashless insurance receivables., targeting a multi-billion dollar gap. We are thrilled to back Shrey, Arpit, and the HealthCRED team to become a major healthcare lender, addressing various financing needs over time.”

HealthCRED is addressing a burgeoning working capital gap in hospitals and the healthcare supply chain, targeting the needs of India's rapidly growing USD 300 Billion+ healthcare industry. With ambitious growth targets, the company aims to disburse over USD 1 Billion over the next 5 years through digital means, basis alternate data driven underwriting.

 

About HealthCRED:
HealthCRED, India’s first B2B healthcare financing startup, is transforming B2B healthcare financing by providing timely capital to the healthcare ecosystem. Founded in 2022 by industry veterans and serial entrepreneurs, Shrey Jain and Arpit Jangir, the Delhi-headquartered company aims to bridge the working capital gap in the healthcare sector. With a focus on technological innovation and data-driven solutions, HealthCRED is committed to enhancing financial access and operational efficiency for healthcare providers across India. HealthCRED’s mission is to become the country’s first healthcare-focused small finance bank.

Tags : #healthcred #healthcare #funding #startupfunding #fundingalert #seedfudning #b2b

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

India’s Pharma Revolution: Can New Regulatory Reforms Unleash a $42 Billion Industry?March 01, 2025
Pregnant and Pained: Is Paracetamol Poisoning Our Unborn Children?March 01, 2025
Are Your Idlis Poisoning You? The Hidden Dangers of Plastic in Indian KitchensMarch 01, 2025
Stuck in Slow Motion: How Bureaucracy is Choking India’s Pharma DreamFebruary 27, 2025
A New Spine, A New Life: Inside Kerala’s First 3D-Printed Titanium Cage SurgeryFebruary 27, 2025
India’s Newborns Are Dying from Sepsis And No One Is Talking About ItFebruary 27, 2025
Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks SoFebruary 26, 2025
The Inequality of Survival: Why Some Women Die While Others LiveFebruary 26, 2025
The Corporate Invasion of Indian Hospitals: What It Means for YouFebruary 26, 2025
5 Simple Daily Habits to Keep Your Joints Healthy and Pain-FreeFebruary 25, 2025
Venus Remedies Secures Exclusive In-Licensing Rights from Infex Therapeutics to Develop and Commercialize MET-X in IndiaFebruary 25, 2025
With only 70 months left to end AIDS why is the urgency missing?February 25, 2025
Drenched in Oil: Is India Cooking Its Way to an Obesity Epidemic?February 25, 2025
Transforming Education: How Online Learning Platforms are Reshaping Study Material for Board and Competitive ExamsFebruary 24, 2025
February 24, 2025
The Dark Side of India’s Pharma Boom: How Banned Drugs Found a New Market in West AfricaFebruary 24, 2025
The Great Indian Medical Education Paradox: More Seats, Fewer Students, Collapsing SystemFebruary 24, 2025
From Science Fiction to Reality: AI Now Detects Blindness Before It StartsFebruary 24, 2025
Will India’s Healthcare Budget Support a Future of Robotic Surgeries?February 22, 2025
Is the World on the Brink of Another Pandemic? Scientists Discover a New Bat VirusFebruary 22, 2025